Literature DB >> 12655350

Tissue transglutaminase in HCV infection.

Roberta Nardacci, Fabiola Ciccosanti, Laura Falasca, Oreste Lo Iacono, Alessandra Amendola, G Antonucci, Mauro Piacentini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12655350     DOI： 10.1038/sj.cdd.4401112

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  3 in total

1.  Prevalence and clinical significance of immunoglobulin A antibodies against tissue transglutaminase in patients with diverse chronic liver diseases.

Authors:  Anastasios E Germenis; Efthalia E Yiannaki; Kalliopi Zachou; Violeta Roka; Sotirios Barbanis; Christos Liaskos; Kalliopi Adam; Andreas N Kapsoritakis; Spyros Potamianos; Georgios N Dalekos
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

2.  Characterization of cell death pathways in human immunodeficiency virus-associated encephalitis.

Authors:  Roberta Nardacci; Andrea Antinori; Luigi Maria Larocca; Vincenzo Arena; Alessandra Amendola; Jean-Luc Perfettini; Guido Kroemer; Mauro Piacentini
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

3.  Inhibiting Transglutaminase 2 Mediates Kidney Fibrosis via Anti-Apoptosis.

Authors:  Jong-Joo Moon; Yejin Choi; Kyu-Hyeon Kim; Areum Seo; Soie Kwon; Yong-Chul Kim; Dong-Ki Kim; Yon-Su Kim; Seung-Hee Yang
Journal:  Biomedicines       Date:  2022-06-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.